OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress
September 08 2016 - 7:30AM
OpGen, Inc. (NASDAQ:OPGN) today announced that it will participate
in the World Anti-Microbial Resistance Congress being held
September 8-9 in Washington, D.C. OpGen CEO Evan Jones will lead a
presentation titled “Harnessing the power of informatics and
genomic analysis to provide complete MDRO solutions” on Thursday,
September 8 at 3:05 p.m. ET.
OpGen will also host a roundtable discussion called “Antibiotic
resistant bacteria in our Integrated Healthcare Network: are new
diagnostic tests needed?” on Friday, September 9 from 1:40 p.m. to
2:20 p.m. ET. The roundtable will feature Bert Lopansri, M.D.,
Associate Professor of Medicine, University of Utah; Chief of
Infectious Diseases, Intermountain Healthcare; and Medical
Director, Urban Central Region Microbiology Lab, Division of
Infectious Diseases and Epidemiology.
About OpGenOpGen, Inc. is harnessing the power
of informatics and genomic analysis to provide complete solutions
for patient, hospital and network-wide infection prevention and
treatment.
OpGen
Michael Farmer
Director, Marketing
(240) 813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
Investor Relations
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
or
Bruce Voss
(310) 691-7100
bvoss@lhai.com
OpGen Media
MacDougall Biomedical Communications
Cammy Duong
781-235-3060
cduong@macbiocom.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Apr 2023 to Apr 2024